SCHEMBL20023686

SCHEMBL20023686

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc3)c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
HPGD P15428 6/20 0.40
ALDH1A1 P00352 5/20 0.40
MAPT P10636 5/20 0.40
NTSR1 P30989 1/20 0.40
PTGER4 P35408 1/20 0.40
TSPO P30536 1/20 0.40
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
NPY5R Q15761 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16261036 1.00 KDM4E (0.43) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL2754537 1.00 KDM4E (0.43) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL2754540 1.00 KDM4E (0.43) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL2754536 0.99 KDM4E (0.42) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17251566 0.96 KMT2A (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17251565 0.96 KMT2A (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL20413117 0.96 KMT2A (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL18565221 0.95 KDM4E (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL20023691 0.95 KDM4E (0.43) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL20413098 0.95 MEN1 (0.42) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10615347-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2020-04-07 US disclosed
US-20180097184-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-04-05 US disclosed
US-20180097184-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180097184-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, SLCO4C1 KDM4E 2370/4885ATM 3931/4885L3MBTL1 829/4885
US-10615347-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD1, OCIAD2, SLCO4C1 KDM4E 2370/4885ATM 3931/4885L3MBTL1 829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.